Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice
J. Clin. Invest. Stephan E. Lehnart, et al. 118:2230 doi:10.1172/JCI35346 [
Go to this article.]

Figure 3Hippocampal
Ryr2RS/WT brain slices and channels exhibit burst activity, which can be inhibited by treatment with ryanodine or the RyR-stabilizing drug S107, respectively.
(
A and
B) Continuous confocal Ca
2+ fluorescence imaging of the
Ryr2RS/WT CA3 principal cell layer under control conditions (left), and seizure activity induced by low Mg
2+ (0.5 mM) plus high K
+ (8.5 mM) (middle) and following ryanodine (10 μM) treatment (right). Fluorescence (F) signals 1–3 in
A correspond to regions of interest indicated by white circles in the CA3 layer in
B. Data are representative of 3 experiments using
Ryr2RS/WT hippocampal slices; dimensions are as indicated. (
C) H&E histology (left) and RyR2 immunohistochemistry (right) of the hippocampal CA3 region in
Ryr2RS/WT brain slices show increased RyR2 expression in the preserved principal cell layer. There were no histological abnormalities compared with WT (data not shown). (
D) Representative
Ryr2RS/WT single-channel traces from vesicles of isolated hippocampus from sedentary mice (left), after injection of NE (5 mg/kg twice over 3 hours; middle) or after 1 week treatment with S107 (5 mg/kg/h) followed by NE treatment (5 mg/kg twice over 3 hours; right).
Po, mean open (To) and mean closed (Tc) times, closed state (c), and the fully open level (4 pA) are indicated. Thick bars above the 5-second traces indicate area shown at higher resolution in the 0.5-second traces. All-point histograms corresponding to the single-channel traces show increased numbers of partial openings (subconductance states) and overall increased activity of the brain channels from NE-treated
Ryr2RS/WT mice (middle histogram). The histogram on the right shows more channels in the closed state (0 pA), consistent with the channel-stabilizing properties of the drug S107 that enhances binding of the calstabin2 subunit to the channel. (
E) Average
Po of WT and
Ryr2RS/WT brain channels under different treatment conditions as indicated. Single-channel measurements were performed at a
cis (cytosolic) Ca
2+ concentration of 150 nM. *
P < 0.05 versus NE-untreated;
†P < 0.05, NE-treated WT versus
Ryr2RS/WT. Each bar represents the average of 7–9 channels. Equivalent amounts of RyR2 were immunoprecipitated from brain homogenates with an RyR2 isoform–specific antibody followed by immunoblotting; bar graphs show the amount of PKA phosphorylation of RyR2 at Ser2808 (
F) and the amount of calstabin2 bound to RyR2 (
G) under the indicated conditions. Animals were treated with S107 via implantable osmotic pumps (5 mg/kg/h) for 7 days before NE stimulation. *
P < 0.05 versus NE-untreated.